These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25788373)

  • 21. Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era.
    Teriaky A; Reau N
    Clin Liver Dis; 2015 Nov; 19(4):591-604, v. PubMed ID: 26466649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of two antiviral agents for hepatitis C genotype 1.
    Lok AS; Gardiner DF; Lawitz E; Martorell C; Everson GT; Ghalib R; Reindollar R; Rustgi V; McPhee F; Wind-Rotolo M; Persson A; Zhu K; Dimitrova DI; Eley T; Guo T; Grasela DM; Pasquinelli C
    N Engl J Med; 2012 Jan; 366(3):216-24. PubMed ID: 22256805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
    Lagging M; Langeland N; Pedersen C; Färkkilä M; Buhl MR; Mørch K; Dhillon AP; Alsiö A; Hellstrand K; Westin J; Christensen P; Leutscher P; Norkrans G;
    Hepatology; 2008 Aug; 48(2):695. PubMed ID: 18666232
    [No Abstract]   [Full Text] [Related]  

  • 24. Lost in translation? IL28B's discovery and the journey back to the patient.
    Clark PJ; Muir AJ
    Hepatology; 2012 Jul; 56(1):5-8. PubMed ID: 22511499
    [No Abstract]   [Full Text] [Related]  

  • 25. Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' reply.
    Maasoumy B; Wedemeyer H
    Aliment Pharmacol Ther; 2014 Mar; 39(5):544-5. PubMed ID: 24494844
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 27. Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
    Takayama K; Furusyo N; Ogawa E; Ikezaki H; Shimizu M; Murata M; Hayashi J
    World J Gastroenterol; 2015 Apr; 21(15):4696-706. PubMed ID: 25914481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.
    Levitsky J; Verna EC; O'Leary JG; Bzowej NH; Moonka DK; Hyland RH; Arterburn S; Dvory-Sobol H; Brainard DM; McHutchison JG; Terrault NA
    N Engl J Med; 2016 Nov; 375(21):2106-2108. PubMed ID: 27959735
    [No Abstract]   [Full Text] [Related]  

  • 29. Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells.
    Coppola N; De Pascalis S; Pisaturo M; Paradiso L; Macera M; Capoluongo N; Alessio L; Stanzione M; Sagnelli C; Minichini C; Sagnelli E
    J Clin Virol; 2013 Dec; 58(4):748-50. PubMed ID: 24140030
    [No Abstract]   [Full Text] [Related]  

  • 30. News in hepatitis C: Report from the 39th annual meeting of the European Association for the Study of the Liver.
    Zeuzem S
    Antivir Ther; 2005; 10(1):179-83. PubMed ID: 15751776
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous interferon-alpha treatment of mixed cryoglobulinemia associated with chronic hepatitis C virus infection.
    Zeller V; Cohen P; Nguyen QT; Lebon P; Dziri S; Ferrière F; Dény P; Guillevin L
    Clin Exp Rheumatol; 2002; 20(4):573-4. PubMed ID: 12175119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of chronic hepatitis C in children].
    Bernard O
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B206-9. PubMed ID: 12180290
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals.
    O'Sullivan K; Levis J; Hegarty K; Crosbie O; Kenny-Walsh E; Fanning LJ
    Hepatology; 2013 Feb; 57(2):855-6. PubMed ID: 22806480
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study.
    Basso M; Zago D; Pozzetto I; Parisi SG
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1076-e1077. PubMed ID: 35048665
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C virus infection: when is a cure not a cure?
    Tillmann HL
    J Infect Dis; 2014 Jan; 209(1):6-8. PubMed ID: 24127562
    [No Abstract]   [Full Text] [Related]  

  • 36. Micromanaging hepatitis C virus.
    Lieberman J; Sarnow P
    N Engl J Med; 2013 May; 368(18):1741-3. PubMed ID: 23534545
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral drugs have made hepatitis C eminently treatable.
    Ladika S
    Manag Care; 2018 Nov; 27(11):23-30. PubMed ID: 30620304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The time factor in the management of chronic hepatitis C].
    Serra MA
    Rev Esp Enferm Dig; 2008 Apr; 100(4):230-5. PubMed ID: 18563981
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C in the United States.
    Holmberg SD; Spradling PR; Moorman AC; Denniston MM
    N Engl J Med; 2013 May; 368(20):1859-61. PubMed ID: 23675657
    [No Abstract]   [Full Text] [Related]  

  • 40. [Not Available].
    Pariente A
    Rev Prat; 2015 Jan; 65(1):29. PubMed ID: 25842421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.